Literature DB >> 8586716

Screening for Escherichia coli O157:H7--a nationwide survey of clinical laboratories.

T G Boyce1, A G Pemberton, J G Wells, P M Griffin.   

Abstract

The Association of State and Territorial Public Health Laboratory Directors has recommended that clinical laboratories screen at least all bloody stools for Escherichia coli O157:H7. We contacted the microbiology supervisors of 230 randomly selected clinical laboratories in the United States and administered a standardized questionnaire regarding stool culture practices. Of the 129 laboratories that performed stool cultures, only 70 (54%) reported screening either all stools or all bloody stools submitted for culture for E. coli O157:H7.

Entities:  

Mesh：

Year:  1995        PMID： 8586716      PMCID： PMC228687          DOI： 10.1128/jcm.33.12.3275-3277.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Results of a 6-month survey of stool cultures for Escherichia coli O157:H7.

Authors:  W F Marshall; C A McLimans; P K Yu; F J Allerberger; R E Van Scoy; J P Anhalt
Journal:  Mayo Clin Proc       Date:  1990-06       Impact factor: 7.616

2.  Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.

Authors:  P I Tarr; M A Neill; C R Clausen; S L Watkins; D L Christie; R O Hickman
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

3.  Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study.

Authors:  C H Pai; N Ahmed; H Lior; W M Johnson; H V Sims; D E Woods
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

4.  Latex agglutination test for detection of Escherichia coli serotype O157.

Authors:  S B March; S Ratnam
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

5.  Frequency of Escherichia coli O157:H7 isolation from stool specimens.

Authors:  F E Cahoon; J S Thompson
Journal:  Can J Microbiol       Date:  1987-10       Impact factor: 2.419

6.  The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

Authors:  D L Martin; K L MacDonald; K E White; J T Soler; M T Osterholm
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

Review 7.  Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.

Authors:  P M Griffin; S M Ostroff; R V Tauxe; K D Greene; J G Wells; J H Lewis; P A Blake
Journal:  Ann Intern Med       Date:  1988-11-01       Impact factor: 25.391

8.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

Authors:  S M Ostroff; J M Kobayashi; J H Lewis
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

9.  Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study.

Authors:  K L MacDonald; M J O'Leary; M L Cohen; P Norris; J G Wells; E Noll; J M Kobayashi; P A Blake
Journal:  JAMA       Date:  1988-06-24       Impact factor: 56.272

10.  Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.

Authors:  P C Rowe; E Orrbine; G A Wells; P N McLaine
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406
View more
  9 in total

1.  A survey of stool culturing practices for vibrio species at clinical laboratories in Gulf Coast states.

Authors:  N N Marano; N A Daniels; A N Easton; A McShan; B Ray; J G Wells; P M Griffin; F J Angulo
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Screening for Escherichia coli O157:H7--a nationwide survey of clinical laboratories.

Authors:  E M Sordillo; M E Nusbaum
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 3.  Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.

Authors:  B E Mahon; P M Griffin; P S Mead; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

4.  Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children.

Authors:  F Allerberger; D Rossboth; M P Dierich; S Aleksic; H Schmidt; H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM.

Authors:  P I Fields; K Blom; H J Hughes; L O Helsel; P Feng; B Swaminathan
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

7.  Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.

Authors:  Patrick J Gavin; Lance R Peterson; Anna C Pasquariello; Joanna Blackburn; Mark G Hamming; Kuo J Kuo; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Shiga toxin-producing Escherichia coli in British Columbia, 2011-2017: Analysis to inform exclusion guidelines.

Authors:  K Noftall; M Taylor; L Hoang; E Galanis
Journal:  Can Commun Dis Rep       Date:  2019-09-05

9.  Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002.

Authors:  Josefa M Rangel; Phyllis H Sparling; Collen Crowe; Patricia M Griffin; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.